MARQIBO KIT Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Marqibo Kit, and when can generic versions of Marqibo Kit launch?

Marqibo Kit is a drug marketed by Acrotech and is included in one NDA.

The generic ingredient in MARQIBO KIT is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for MARQIBO KIT?
What are the global sales for MARQIBO KIT?
What is Average Wholesale Price for MARQIBO KIT?

Summary for MARQIBO KIT

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	48
Clinical Trials:	30
Patent Applications:	3,125
Drug Prices:	Drug price information for MARQIBO KIT
DailyMed Link:	MARQIBO KIT at DailyMed

Drug patent expirations by year for MARQIBO KIT

Recent Clinical Trials for MARQIBO KIT

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	Phase 1
David Rizzieri, MD	Phase 2
Acrotech Biopharma	Phase 2

See all MARQIBO KIT clinical trials

US Patents and Regulatory Information for MARQIBO KIT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MARQIBO KIT

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
Acrotech	MARQIBO KIT	vincristine sulfate	INJECTABLE, LIPOSOMAL;INTRAVENOUS	202497-001	Aug 9, 2012	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for MARQIBO KIT

See the table below for patents covering MARQIBO KIT around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Spain	2253398		⤷ Sign Up
Japan	H10501534		⤷ Sign Up
Australia	7041301		⤷ Sign Up
European Patent Office	1299084	MEDICAMENTS ANTINEOPLASIQUES LIPOSOMAUX ET LEURS UTILISATIONS (LIPOSOMAL ANTINEOPLASTIC DRUGS AND USES THEREOF)	⤷ Sign Up
World Intellectual Property Organization (WIPO)	0202077		⤷ Sign Up
World Intellectual Property Organization (WIPO)	0202078		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for MARQIBO KIT

Recent Clinical Trials for MARQIBO KIT

Make Better Decisions: Try a trial or see plans & pricing